EUVIMEDEUVIMED entdecken
Crossref

The Profile of Lung Adenocarcinoma Patients with Positive EGFR Mutation

Edward Pandu Wiriansya, Ainun, Puspa Ratu, Andi Muhammad Reza Cesarian Noor

Green Medical Journal · 2020

DOI: 10.33096/gmj.v2i1.37 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Green Medical Journal, 2020. Verfasst von Edward Pandu Wiriansya und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The high mortality rate in pulmonary carcinoma is a problem encountered in various countries, including Indonesia. According to WHO, there are 2.09 million people affected by lung cancer and 1.76 million deaths due to lung cancer worldwide. This study was aimed to determine the profile of lung adenocarcinoma patients with positive EGFR mutation.

Methods

The study was descriptive study with cross-sectional approach using secondary data obtained from medical records of lung adenocarcinoma patients.

Results

The present study revealed that lung adenocarcinoma was found higher in patients with age >40 years old (93.9%) compared to those with age

Zitieren

APA

Wiriansya, E. P., Ainun, Ratu, P., & Noor, A. M. R. C. (2020). The Profile of Lung Adenocarcinoma Patients with Positive EGFR Mutation. Green Medical Journal. https://doi.org/10.33096/gmj.v2i1.37

Vancouver

Wiriansya EP, Ainun, Ratu P, Noor AMRC. The Profile of Lung Adenocarcinoma Patients with Positive EGFR Mutation. Green Medical Journal. 2020. doi:10.33096/gmj.v2i1.37

BibTeX
@article{Wiriansya2020,
  author = {Wiriansya, Edward Pandu and Ainun and Ratu, Puspa and Noor, Andi Muhammad Reza Cesarian},
  title = {The Profile of Lung Adenocarcinoma Patients with Positive EGFR Mutation},
  journal = {Green Medical Journal},
  year = {2020},
  doi = {10.33096/gmj.v2i1.37}
}
Kostenlos starten →